Similar tenders from other countries.
Showing 1 to 20
Purchase Of Blank Products For 2025
24 Jan 2025
07 Feb 2025Framework Agreement With A Single Supplier For The Supply Of Medicines For Hospital Use For The Treatment Of Multiple Sclerosis And Human Immunodeficiency Virus (Hiv) Infection To The Hospitals Of The Extremadura Health Service.
Accreditation Of A Legal Entity To Provide Medical Consultation Services In The Territory Of Coronel Fabriciano, In Accordance With The "Table Of Procedures, Medicines, Orthoses And Prostheses And Special Materials Opm Of The Unified Health System - Sus", With The Source Of Revenue Being Fund-To-Fund Transfers Of Sus Resources From The Federal Government.
Supply of Medicine and Medical / Surgical equipments : Dried Recombinant Factor, VIII Fraction\n500IU vial\nDried Recombinant Factor VIII Fraction 500IU vial\nDried factor VIII Fraction BP (Dried Recombinant\nAntihaemophilic Fraction) 500IU vial\nOR\nRecombinant Coagulation Factor VIII Ph Eur.\n500IU vial\nOR\nRecombinant Antihemophilic Factor USP 500IU vial\nOR\nDried Recombinant Antihaemophilic Fraction IP\n500IU vial\nEach vial to contain 500IU of concentrated,\npurified and viruses inactivated 3rd or 4th\ngeneration recombinant dried factor VIII Fraction\nBP, Ph Eur, USP or IP.\nNote:\n1. The item should be stable at temperature 2oC –\n8oC.\n2. The product should have minimum 24 months\nshelf life at the time of delivery to MSD.\n3. Tenderer should submit detailed specifications\nof the product offered.\n4. The product should ensure, at least two steps\non virus inactivation as recommended by\nWHO/US.FDA\n5. The purification process should be specified by\nthe manufacturer.\n6. Each batch should be certified as free from HIV\nhepatitis and other viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared by\nthe manufacturer. The test methods used should\nbe approved by WHO/US.FDA.\n8. Each vial to be supplied with suitable diluent.\n9. The product should be protected from light.\nPacking : 10 vials in a Pack etc .
Invitation To Bid (Itb) Unfpa/Dnk/Itb/24/025 For Establishment Of Global Blanket Purchase Agreements For Anatomical And Vocational Models
Framework Agreement For The Supply Of Medicines Within The Oncology Pn, Cost Volum - Sub-Program For The Treatment Of Patients With Oncological Diseases, Pn For The Treatment Of Rare Diseases - Dsma, Pn For The Prevention, Surveillance And Control Of Hiv/Aids Infection
Framework Agreement For The Supply Of Medicines Within The Oncology Pn, Cost Volum - Sub-Program For The Treatment Of Patients With Oncological Diseases, Pn For The Treatment Of Rare Diseases - Dsma, Pn For The Prevention, Surveillance And Control Of Hiv/Aids Infection
Supply of Medicine and Medical / Surgical equipments : Antitetanus Human Immunoglobulin 250IU\nAmpoule/Vial/Prefilled syringe\nAntitetanus Human Immunoglobulin 250IU\nAmpoule/Vial/Prefilled syringe\nEach ampoule/vial/prefilled syringe to contain\n250IU of Antitetanus Immunoglobulin obtained\nfrom Human Plasma containing specific anti\nbodies against Clostridium tetani suitable for\nintramuscular or intravenous injection.\nNote:\n1.This injection should be stable for 24 months\nwhen stored within a temperture range of 2'C-8'C.\nDo not freeze.\n2.The manufacturer should submit a certificate for\neach batch of the product that it has been tested\nfree of Hepatitis B,Hepatitis C and HIV infections.\n3.Each ampoule/vial/prefilled syringe should be\nlabelled accordingly. etc .
Supply of Medicine and Medical / Surgical equipments : Dried Recombinant Factor VIII Fraction 200IU-\n350IU vial\nDried Recombinant Factor VIII Fraction 200IU-\n350IU vial\nDried factor VIII Fraction BP (Dried Recombinant\nAntihaemophilic Fraction) 200IU-350IU vial\nOR\nRecombinant Coagulation Factor VIII Ph Eur.\n200IU-350IU vial\nOR\nRecombinant Antihemophilic Factor USP 200IU-\n350IU vial\nOR\nDried Recombinant Antihaemophilic Fraction\nIP200IU-350IU vial\nEach vial to contain 200IU-350IU of concentrated,\npurified and viruses inactivated 3rd or 4th\ngeneration recombinant dried factor VIII Fraction\nBP, Ph Eur, USP or IP.\nNote:\n1. The item should be stable at temperature 2oC –\n8oC.\n2. The product should have minimum 24 months\nshelf life at the time of delivery to MSD.\n3. Tenderer should submit detailed specifications\nof the product offered.\n4. The product should ensure, at least two steps on\nvirus inactivation as recommended by\nWHO/US.FDA\n5. The purification process should be specified by\nthe manufacturer.\n6. Each batch should be certified as free from HIV\nhepatitis and other viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared by\nthe manufacturer. The test methods used should\nbe approved by WHO/US.FDA.\n8. Each vial to be supplied with suitable diluent.\n9. The product should be protected from light. etc .
Providing for for Medical Products for the ECOWAS Joint Assessment Procedure under the West Africa Medicines Regulatory Harmonization (WA-MRH)
Annual Public Procurement Program For 2025
Hainan Provincial Women And Children'S Medical Center-2024 Hainan Province Prevention Of Mother-To-Child Transmission Of Hiv, Syphilis And Hepatitis B Reagents And Drugs Procurement Project.
Paap 2024
The Provision Of Outpatient Pharmacy Services For University Hospitals Morecambe Bay Nhs, Blackpool Teaching Hospital Nhs, East Lancashire Hospitals Nhs And Lancashire Teaching Hospitals Nhs Trusts.
Annual Public Procurement Program 2024
Annual Public Procurement Program
Annual Public Procurement Program 2024
Paap 2024
Annual Public Procurement Program
Paap 2024
Tenders by Country